Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.12% |
| 2 | Healthcare | 2.55% |
| 3 | Financials | 2.39% |
| 4 | Consumer Discretionary | 2.14% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4376
PUT
Cavco Industries
CVCO
$4.65B
| $3.6M | ﹤0.01% |
17,500
+8,900
| +103% | +$2.11M |
|
|
IBTE
4377
DELISTED
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
| $3.6M | ﹤0.01% |
150,350
+100,350
| +201% | +$2.43M |
|
4378
CALL
Altimmune
ALT
$572M
| $3.6M | ﹤0.01% |
281,600
+104,000
| +59% | +$1.54M |
|
4379
Pacer US Cash Cows 100 ETF
COWZ
$19.8B
| $3.6M | ﹤0.01% |
87,656
+59,797
| +215% | +$2.69M |
|
4380
Franklin Electric
FELE
$4.68B
| $3.6M | ﹤0.01% |
44,008
+24,079
| +121% | +$2.05M |
|
4381
CALL
Gossamer Bio
GOSS
$75.4M
| $3.6M | ﹤0.01% |
300,200
-36,200
| -11% | -$449K |
|
4382
CALL
Wintrust Financial
WTFC
$11B
| $3.6M | ﹤0.01% |
44,100
+34,600
| +364% | +$2.94M |
|
4383
CALL
West Pharmaceutical
WST
$24.6B
| $3.59M | ﹤0.01% |
14,600
+2,200
| +18% | +$670K |
|
4384
PUT
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$39.8M
| $3.59M | ﹤0.01% |
14,980
+3,360
| +29% | +$781K |
|
|
DMC
4385
Del Monte Corp
DMC
$1.43B
| $3.58M | ﹤0.01% |
154,279
+72,598
| +89% | +$2.02M |
|
|
EGRX
4386
CALL
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.58M | ﹤0.01% |
+135,700
| New | +$4.98M |
|
|
OSTR
4387
DELISTED
Oyster Enterprises Acquisition Corp. Class A Common Stock
OSTR
| $3.58M | ﹤0.01% |
362,984
-2,000
| -0.5% | -$19.7K |
|
4388
PUT
Eastman Chemical
EMN
$8.47B
| $3.58M | ﹤0.01% |
50,400
-42,700
| -46% | -$3.84M |
|
4389
Trex
TREX
$5.06B
| $3.58M | ﹤0.01% |
81,411
-70,034
| -46% | -$3.75M |
|
|
AVNS
4390
DELISTED
Avanos Medical
AVNS
| $3.57M | ﹤0.01% |
164,067
+68,933
| +72% | +$1.8M |
|
4391
Scholastic
SCHL
$781M
| $3.57M | ﹤0.01% |
116,062
+77,925
| +204% | +$3.25M |
|
4392
Valaris
VAL
$5.95B
| $3.57M | ﹤0.01% |
72,911
-86,101
| -54% | -$4.13M |
|
4393
CALL
Abercrombie & Fitch
ANF
$4.8B
| $3.57M | ﹤0.01% |
229,300
-242,900
| -51% | -$4.19M |
|
4394
CALL
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
| $3.57M | ﹤0.01% |
37,100
+17,000
| +85% | +$1.7M |
|
4395
Harmony Gold Mining
HMY
$12.1B
| $3.56M | ﹤0.01% |
1,467,113
+1,322,077
| +912% | +$3.83M |
|
|
JNPR
4396
CALL
DELISTED
Juniper Networks
JNPR
| $3.56M | ﹤0.01% |
136,500
-145,300
| -52% | -$4.1M |
|
|
GTLS
4397
CALL
DELISTED
Chart Industries
GTLS
| $3.56M | ﹤0.01% |
19,300
+2,600
| +16% | +$482K |
|
|
TRTX
4398
TPG RE Finance Trust
TRTX
$609M
| $3.55M | ﹤0.01% |
507,660
+301,735
| +147% | +$2.87M |
|
4399
Zions Bancorporation
ZION
$10.5B
| $3.55M | ﹤0.01% |
69,867
-461,653
| -87% | -$25.2M |
|
4400
PUT
StoneCo
STNE
$2.32B
| $3.55M | ﹤0.01% |
372,700
-282,900
| -43% | -$2.71M |
|
Similar funds
Ken Griffin's Q3 2022 Portfolio in Review
As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.
- Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
- Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
- Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.